Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients-Reference-Cited by-同舟云学术

Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients

Published:2021-12 Issue:12 Volume:32 Page:1642-1645
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Aldea M.,Cerbone L.,Bayle A.,Parisi C.,Sarkozy C.,Vasseur D.,Verlingue L.,Blanc-Durand F.,Mosele F.,Sakkal M.,Ponce S.,Lavaud P.,Loriot Y.,Hollebecque A.,Massard C.,Soria J.-C.,Lacroix L.,Rouleau E.,Italiano A.

Funder

Roche

Bayer

Daiichi-Sankyo

GlaxoSmithKline

Gustave Roussy

Ipsen

AstraZeneca

Merck

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference8 articles.

1. Liquid biopsy: from discovery to clinical application;Alix-Panabieres;Cancer Discov,2021

2. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants;Razavi;Nat Med,2019

3. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin;Woodhouse;PLoS One,2020

4. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer;Tomlins;Science,2005

5. Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing;Parry;Clin Cancer Res,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group;Annals of Oncology;2024-07

2. Circulating tumor DNA: from discovery to clinical application in breast cancer;Frontiers in Immunology;2024-04-30

3. Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients;npj Precision Oncology;2024-02-26

4. Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?;ESMO Open;2023-10

5. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors;JCO Precision Oncology;2023-03